Functional Assessment by UFR in Patients With Suspected Ischemic Heart Disease (FEATURE)

Sponsor
Ruijin Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05694065
Collaborator
(none)
112
1
11
10.2

Study Details

Study Description

Brief Summary

Investigating the diagnostic accuracy of online Ultrasonic Flow Ratio (UFR) assessment to identify hemodynamically significant coronary stenosis in patients with suspected ischemic heart disease using angiography-derived fractional flow reserve (FFR) as a reference standard.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This is a prospective, single-center, observational registry study of patients with suspected ischemic coronary artery disease. The purpose of this registry is to investigate the accuracy of online UFR assessment to identify hemodynamically significant coronary stenosis in patients with suspected ischemic heart disease using angiography-derived FFR as a reference standard.

    Study population and sample size calculation are based on the diagnostic performance of previous studies, where an accuracy of 92% was found for UFR. Investigators conservatively estimate the diagnostic accuracy of online UFR assessment as 90% for consecutively enrolled patient population, and with a test target value set as 78% at a two-side significance level of 0.05, statistical power as 90%. Considering incomplete FFR/UFR data of 10% at most, a total of 112 patients need to be enrolled.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    112 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Functional Assessment by Intravascular Ultrasound Reconstruction in Patients With Suspected Ischemic Coronary Artery Disease (FEATURE)
    Anticipated Study Start Date :
    Jan 30, 2023
    Anticipated Primary Completion Date :
    Nov 30, 2023
    Anticipated Study Completion Date :
    Dec 31, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Diagnostic accuracy of online UFR as compared with FFR [baseline]

      The diagnostic accuracy of online UFR assessment to identify hemodynamically significant coronary stenosis with FFR as the reference standard.

    Secondary Outcome Measures

    1. Sensitivity and specificity of online UFR as compared with minimum lumen area (MLA) [baseline]

      The superiority in sensitivity and specificity for online UFR in comparison to MLA, when using FFR as a golden standard.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Subject must be ≥ 18 years

    • Patients suspected with ischemic heart disease

    • ≥ 1 diseased vessel with angiographic percent diameter stenosis between 40% and 80% in a vessel ≥ 2.5mm by visual estimation

    • Target vessels are limited to major epicardial coronary arteries (left anterior descending artery [LAD], left circumflex artery [LCX], right coronary artery [RCA])

    Exclusion Criteria:
    • Patients with previous coronary artery bypass grafting (CABG)

    • Myocardial infarction within 72h of coronary angiography

    • Allergy to the contrast agent or adenosine

    • Left main coronary artery stenosis ≥ 50%

    • Target vessel with in-stent restenosis

    • Target vessel with severe tortuosity or angulation

    • 100% occlusion of target vessel

    • Target vessel spasm or injury

    • Target vessel with severe myocardial bridge

    • Target vessel with severe thrombosis

    • Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion

    • Presence of false lumen at target vessel based on IVUS

    • A serum creatinine level >150 umol/l, or a glomerular filtration rate < 45 ml/kg/1.73 m^2

    • Heart failure

    • Ineligible for diagnostic intervention (IVUS or FFR examination)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai Shanghai China 200025

    Sponsors and Collaborators

    • Ruijin Hospital

    Investigators

    • Principal Investigator: Fenghua Ding, MD, PhD, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ruijin Hospital
    ClinicalTrials.gov Identifier:
    NCT05694065
    Other Study ID Numbers:
    • 20221110025331724
    First Posted:
    Jan 23, 2023
    Last Update Posted:
    Jan 31, 2023
    Last Verified:
    Jan 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 31, 2023